Ligand Pharmaceuticals
(NASDAQ) LGND
Ligand Pharmaceuticals Financials at a Glance
Market Cap
$5.71B
Revenue (TTM)
$274.48M
Net Income (TTM)
$153.56M
EPS (TTM)
$7.38
P/E Ratio
38.63
Dividend
$0.00
Beta (Volatility)
1.05 (Average)
Dividend
$0.00
Beta (Volatility)
1.05 (Average)
Price
$285.37
Volume
1.891
Open
$283.35
Price
$285.37
Volume
1.891
Open
$283.35
Previous Close
$284.91
Daily Range
$278.65 - $288.46
52-Week Range
$111.72 - $288.46
Estimated Earnings Date
Aug 6, 2026
Dividend
$0.00
Beta (Volatility)
1.05 (Average)
Price
$285.37
Volume
1.891
Open
$283.35
Previous Close
$284.91
Daily Range
$278.65 - $288.46
52-Week Range
$111.72 - $288.46
Estimated Earnings Date
Aug 6, 2026
LGND News
LGND: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Ligand Pharmaceuticals
Industry
Pharmaceuticals
Sector
Health CareEmployees
47
CEO
Todd Christopher Davis, MBA
Website
www.ligand.comHeadquarters
Jupiter, CA 94608, US
LGND Financials
Key Financial Metrics (TTM)
Gross Margin
98.61%
Operating Margin
36.72%
Net Income Margin
55.95%
Return on Equity
16.19%
Return on Capital
3.21%
Return on Assets
10.02%
Earnings Yield
2.59%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$5.71B
Shares Outstanding
20.04M
Volume
1.891
Avg. Volume
272.68K
Financials (TTM)
Gross Profit
$270.66M
Operating Income
$100.78M
EBITDA
$222.24M
Operating Cash Flow
$123.42M
Capital Expenditure
-$466.00K
Free Cash Flow
$122.96M
Cash & ST Invst.
$779.41M
Total Debt
$451.98M
Ligand Pharmaceuticals Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$51.72M
+14.1%
Gross Profit
$49.65M
+22.6%
Gross Margin
95.99%
N/A
Market Cap
$5.71B
N/A
Market Cap/Employee
$83.97M
N/A
Employees
68
N/A
Net Income
-$13.35M
+68.6%
EBITDA
-$14.30M
+64.7%
Quarterly Fundamentals
Total Cash
$779.41M
+273.1%
Total Debt
$451.98M
+10061.4%
Accounts Receivable
$54.80M
+27.9%
Inventory
$13.27M
+12.3%
Long Term Debt
$450.89M
+12547.7%
Short Term Debt
$1.09M
+23.2%
Return on Assets
10.02%
N/A
Return on Invested Capital
6.76%
N/A
Free Cash Flow
$48.46M
+288.4%
Operating Cash Flow
$48.69M
+290.8%